IM Cannabis to Acquire Trichome in Landmark Transaction – Establishes Global Growth Platform and Leading Multi-Country Operator Combined Company will be a fully-integrated global leader in adult-use recreational and...
MONCTON, New Brunswick, August 14, 2020–(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis,...
Organigram and Canndoc Sign International Strategic Agreement Organigram to supply Israeli leader Canndoc with up to 6,000kg of dried flower in multi-year strategic agreement; Organigram’s largest international deal to...
Syqe Medical Receives Regulatory Approval to Release World’s First Drug Delivery Device for Precise Dosing of Cannabis Leading pharma-tech company launches its first-in-class, pharmaceutical-grade cannabis inhaler in Israel; enabling...
Cronos Group Opens Cronos Device Labs, New Global R&D Center in Israel Accelerates Efforts to Develop Next-Generation Vaporizer Products Designed Specifically for Cannabinoids TORONTO, May 07, 2019 (GLOBE NEWSWIRE)...
Cannabis Science Pioneer Tikun Olam Announces Closing of $7 Million Convertible Promissory Notes Financing NEW YORK, NY (March 9, 2018) – Tikun Olam USA, the world pioneer in cannabis research,...
Bazelet Completes New World-Scale Manufacturing Plant and Develops New Patent-Pending Cannabis Formulations with Improved Therapeutic Effects TEL AVIV, Israel, November 28, 2017 /PRNewswire/ — Israeli Medical Cannabis Company Bazelet...
Cronos Establishes International Low Cost Production in Israel TORONTO, Sept. 6, 2017 /CNW/ – Cronos Group Inc. (TSXV: MJN) (OTC: PRMCF) (“Cronos” or the “Company”) is pleased to announce...
Tikun Olam, the World’s Original Medical Cannabis Company, Announces US Expansion of Health & Wellness Brand: Tikun™ NEW YORK, April 20, 2017 /PRNewswire/ — The United States will experience...
Therapix Biosciences Ltd. Announces Pricing of U.S. Initial Public Offering and NASDAQ Listing TEL AVIV, Israel, March 22, 2017 /PRNewswire/ — Therapix Biosciences Ltd. (NASDAQ: TRPX) (TASE: THXBY), a...
Therapix Biosciences announces enrollment of the first patient for clinical trial at Yale University for treating Tourette’s syndrome using cannabinoid-based drug TEL AVIV, Israel, January 4, 2017 /PRNewswire/ —...
Israeli cannabis device maker Syqe Medical, which includes Philip Morris International as a major investor, has signed Teva Pharmaceuticals (NYSE: TEVA) to distribute its inhaler following its approval by...
Health Canada continues to add licensed producers (LPs) to its federal medical cannabis program, Marihuana for Medical Purposes Regulations (MMPR), naming United Greeneries to the approved list today. The...
Turnkey dispensary operator and cultivator Ultra Health, based in Arizona with extensive operations in New Mexico and expanding to Nevada, has turned to an Israeli company, Panaxia, to make its medical...
While legalization of cannabis continues at a torrid pace in the United States on a state-by-state basis, the trends are global. New Frontier has created a first-of-its-kind report that examines...
